Company Monitoring Page for Incyte

latest headlines for company on cafepharma

The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
Tags:
ASCO 2018, European Society of Cardiology, TherapeuticsMD, Abiomed, Incyte, Bluebird Bio, Celgene, Syndax, Loxo Oncology, Exelixis, Karyopharm, Endocyte, Celldex Therapeutics, Jounce Therapeutics, Bristol-Myers Squibb, Nektar
Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination
Fierce Biotech
Wed, 05/2/18 - 09:55 am
Tags:
Incyte, epacadostat, Keytruda, IDO inhibitors
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Tags:
Eli Lilly, FDA, advisory panels, rheumatoid arthritis, baricitinib, Incyte
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Sun, 04/22/18 - 12:12 pm
Tags:
Eli Lilly, earnings, FDA, Incyte, olumiant, rheumatoid arthritis
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Fri, 04/20/18 - 12:44 pm
Tags:
Incyte, TG Therapeutics, Cara Therapeutics, CR845, opioids, ublituximab, leukemia, olumiant, rheumatoid arthritis
[video]Why One Drug Flop Tanked Incyte's Stock
Motley Fool
Thu, 04/12/18 - 10:58 pm
Tags:
Incyte, epacadostat
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Tags:
Incyte, Merck, epacadostat, IDO inhibitors, Roche, NewLink Genetics
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
Motley Fool
Fri, 04/6/18 - 07:41 pm
Tags:
Nektar Therapeutics, Incyte, Merck, NKTR-214, Bristol-Myers Squibb
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Marketwatch
Fri, 04/6/18 - 09:51 am
Tags:
Incyte, Merck, melanoma, epacadostat, Keytruda, clinical trials, metastatic melanoma
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
Tags:
biotech, GW Pharma, Epidiolex, Incyte, olumiant, baricitinib, Neurocrine Biosciences, Elagolix
Incyte study could bring lessons for cancer immunotherapy
Biopharma Dive
Wed, 03/14/18 - 11:27 am
Tags:
Incyte, cancer immunotherapy, metastatic melanoma, Merck, Keytruda
Concert rethinks R&D plans after loss in Incyte patent case
Fierce Biotech
Fri, 01/12/18 - 06:40 pm
Tags:
Concert Pharmaceuticals, Incyte, patents, R&D, CTP-543
JPM18: Incyte and Syros to collaborate in cancer R&D
Biopharma Dive
Wed, 01/10/18 - 06:57 pm
Tags:
Incyte, Syros Pharmaceuticals, cancer, R&D, JPMHC 2018
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Tags:
Gilead Sciences, Bictegravir/F/TAF, Novo Nordisk, semaglutide, Ozempic, Incyte, epacadostat, AbbVie, Rova-T, Celgene, ozanimod
Why These 3 Biotech Stocks Could Outperform Their Peers In 2018
Investors Business Daily
Sat, 01/6/18 - 12:32 pm
Tags:
biotech, Puma Biotechnology, Incyte, Clovis Oncology
3 Promising Cancer Immunotherapies to Watch in 2018
Yahoo/Motley Fool
Fri, 12/22/17 - 09:46 am
Tags:
cancer, immuno-oncology, Incyte, epacadostat, Bristol-Myers Squibb, relatlimab, Nektar, NKTR-214
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
Tags:
drug launches, Bictegravir/F/TAF, Gilead Sciences, semaglutide, Novo Nordisk, epacadostat, Incyte, Rova-T, AbbVie, ozanimod, Celgene, apalutamide, JNJ, Elagolix, AVXS-101, AveXis, lanadelumab, Shire, Epidiolex, GW Pharma
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
Tags:
M&A, Allergan, Alnylam, Biomarin, Bristol-Myers Squibb, Incyte, Madrigal Pharmaceuticals, Spark Therapeutics, Sucampo
Bristol-Myers offers a positive snapshot on early data for an IDO1 rival to Incyte
Endpoints
Fri, 11/10/17 - 11:35 am
Tags:
Bristol-Myers Squibb, IDO1, BMS-986205, Incyte, bladder cancer, cervical cancer
AstraZeneca plans new pivotal lung cancer trial with Incyte
Yahoo/Reuters
Tue, 10/31/17 - 10:04 am
Tags:
AstraZeneca, Incyte, clinical trials, Imfinzi, epacadostat, lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.